These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 394311)

  • 21. Plasma insulin is removed by hemodialysis: evaluation of the relation between plasma insulin and glucose by using a dialysate with or without glucose.
    Abe M; Kaizu K; Matsumoto K
    Ther Apher Dial; 2007 Aug; 11(4):280-7. PubMed ID: 17661834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritoneal dialysis in diabetic patients.
    Bertoli M; Bonfante L; Gambaro G; Cara M; Virgilio B; D'Angelo A
    Contrib Nephrol; 2001; (131):51-60. PubMed ID: 11125563
    [No Abstract]   [Full Text] [Related]  

  • 23. Hemodialysis-induced hypoglycemia in diabetic patients.
    Jackson MA; Holland MR; Nicholas J; Lodwick R; Forster D; Macdonald IA
    Clin Nephrol; 2000 Jul; 54(1):30-4. PubMed ID: 10939754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. End-stage diabetic nephropathy. Discussion: technical aspects of dialysis.
    Kidney Int Suppl; 1974 Oct; (1):115-28. PubMed ID: 4533906
    [No Abstract]   [Full Text] [Related]  

  • 25. The metabolic effects of hemodialysis with and without glucose in the dialysate.
    Wathen RL; Keshaviah P; Hommeyer P; Cadwell K; Comty CM
    Am J Clin Nutr; 1978 Oct; 31(10):1870-5. PubMed ID: 707341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraperitoneal administration of insulin during peritoneal dialysis of diabetics with terminal renal failure.
    Anderson KE; Petersen PH
    Int J Artif Organs; 1981 Jul; 4(4):162-7. PubMed ID: 7035377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uremic hyperlipoproteinemia: correlation with residual renal function and duration of maintenance hemodialysis.
    Frank W; Rao TK; Manis T; Delano BG; Avram MM; Saxena AK; Carter AC; Friedman EA
    Trans Am Soc Artif Intern Organs; 1977; 23():59-64. PubMed ID: 910386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemo- and peritoneal dialysis treatment of patients with diabetic nephropathy--a comparative study.
    Quelhorst E; Schuenemann B; Mietzsch G; Jacob I
    Proc Eur Dial Transplant Assoc; 1978; 15():205-12. PubMed ID: 740664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. End-state renal failure in diabetic nephropathy: pathophysiology and treatment.
    Schmitz O; Hansen HE; Orskov H; Mogensen CE; Posborg Petersen V
    Blood Purif; 1985; 3(1-3):120-39. PubMed ID: 3913447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of diabetic control to development of microvascular complications.
    Tchobroutsky G
    Diabetologia; 1978 Sep; 15(3):143-52. PubMed ID: 359393
    [No Abstract]   [Full Text] [Related]  

  • 31. Chronic ambulatory peritoneal dialysis.
    Harrington JT
    N Engl J Med; 1982 Mar; 306(11):670-1. PubMed ID: 7035948
    [No Abstract]   [Full Text] [Related]  

  • 32. Is continuous ambulatory peritoneal dialysis the best dialysis choice for insulin dependent diabetics?
    Rottembourg J; de Groc F; Poignet JL; Legrain M
    Proc Eur Dial Transplant Assoc; 1983; 19():215-20. PubMed ID: 6348737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dialyzer membrane permeability and survival in hemodialysis patients.
    Chauveau P; Nguyen H; Combe C; Chêne G; Azar R; Cano N; Canaud B; Fouque D; Laville M; Leverve X; Roth H; Aparicio M;
    Am J Kidney Dis; 2005 Mar; 45(3):565-71. PubMed ID: 15754279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abysmal prognosis of patients with type 2 diabetes entering dialysis.
    Chantrel F; Enache I; Bouiller M; Kolb I; Kunz K; Petitjean P; Moulin B; Hannedouche T
    Nephrol Dial Transplant; 1999 Jan; 14(1):129-36. PubMed ID: 10052492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodialysis-related problems in patients with diabetes mellitus.
    Kaississieh SD; Yen MC; Lazarus M; Lowrie EG; Goldstein HH; Takacs FJ; Hampers CL; Merrill JD
    Kidney Int Suppl; 1974 Oct; (1):100-7. PubMed ID: 4533904
    [No Abstract]   [Full Text] [Related]  

  • 36. The treatment of end-stage renal failure in insulin-dependent diabetic patients.
    Thayssen P; Roed-Petersen K; Nielsen FU; Svendsen V; Kemp E
    Acta Med Scand; 1977; 201(5):469-80. PubMed ID: 331880
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin antibody binding in diabetes mellitus and factitious hypoglycemia.
    Palumbo PJ; Molnar GD; Taylor WF; Moxness KE; Tauxe WN
    Mayo Clin Proc; 1969 Oct; 44(10):725-37. PubMed ID: 5344806
    [No Abstract]   [Full Text] [Related]  

  • 38. [Serum concentration of lactate in diabetic patients treated with biguanides in relationship to renal function (author's transl)].
    Sailer D; Ganawal S; Berg G
    Med Klin; 1979 Mar; 74(9):318-24. PubMed ID: 423858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraperitoneal insulin during peritoneal dialysis for patients with diabetes and renal failure.
    Krothapalli R; Patel HS; Lacke C; Payne W; Knight TF; Senekjian HO; Weinman EJ
    South Med J; 1983 Apr; 76(4):512-4. PubMed ID: 6340216
    [No Abstract]   [Full Text] [Related]  

  • 40. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.